Concomitant mutations, including the TP53 tumor suppressor gene, serine/threonine kinase 11 (STK11) and kelch-like ECH-associated protein 1 (KEAP1) have been reported in about half of KRAS-mutant NSCLC [18]. Here, KRAS is linked to non-small cell lung carcinoma.